China moves to streamline medtech regulatory process

05/20/2013 | (Boston)

The China Food and Drug Administration has adopted measures to enhance its process for medical device classification, including setting up a system to allow firms to submit their product classification requests online. The agency also hopes to streamline the regulatory pathway for innovative devices in China by developing a special approval program for such products.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL